Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy
Titel:
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy
Auteur:
Kim, Ji-Won Kim, Jee Hyun Im, Seock-Ah Lee, Kyung-Hun Kim, Jin-Soo Kim, Tae-Yong Han, Sae-Won Jeon, Yoon Kyung Oh, Do-Youn Kim, Tae-You Park, In Ae